Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 03, 2024, titled "Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India".
Glenmark Pharmaceuticals Limited Press Release Jan 03 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Nov 10 2023
- Press Release Nov 07 2023
- Press Release Oct 18 2023
- Press Release Oct 17 2023
- Press Release Oct 12 2023
Later from Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals Limited Press Release Jan 25 2024
- Press Release Jan 30 2024
- Press Release Jan 31 2024
- Press Release Feb 14 2024
- Glenmark Pharmaceuticals Limited Press Release Apr 29 2024
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals